News
Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy: Basel Tuesday, April 15, 2025, 10:00 Hrs [IST] Roche ann ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback